TNNT2 and persistent truncus arteriosus: Mice with cTnT‐shHIPK1‐AAV9 gene therapy had a significant improvement of cardiac function (Figure5a and Figure S11, Table S4, Supporting Information) and a reduction of hypertrophic heart weight after TAC surgery (Figure 5b).